Best in 7 days Comparison of the MT1 and MT2 structures in their active and inactive US$ 28.51 Sold : Login>>
Three new #obesity drugs—high-dose semaglutide, semaglutide plus cagrilintide, and oral orforglipron—may soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how US$ 23.59 Min. order: 1 piece ★★★★★ 4.6 (159 reviews) Sold : Login>>
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity US$ 29.56 Min. order: 1 piece ★★★★★ 4.9 (40 reviews) Sold : Login>>
A new era in gut hormone-based pharmacotherapy for people with obesity | Proceedings of the Nutrition Society US$ 20.65 Min. order: 1 piece ★★★★★ 4.0 (74 reviews) Sold : Login>>